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Ranking hospitals based on preventable hospital death rates: A Systematic Review with 
implications for both direct measurement and indirect measurement through 
standardized mortality rates. 
 
ABSTRACT 
Objectives: There is interest in monitoring avoidable or preventable deaths measured 
directly or indirectly through standardized mortality rates (SMRs). We reviewed studies that 
use implicit case note reviews to estimate the range of preventable death rates observed, 
the measurement characteristics of those estimates, and the measurement procedures 
used to generate them. We comment on the implications for monitoring SMRs and illustrate 
a way to calculate the number of reviews needed to establish a reliable estimate of 
preventability of one death or the hospital preventable death rate. 
Design: Systematic review of the literature supplemented by re-analysis of authors 
previously published and un-published data and measurement design calculations. 
Data source: Searches in PubMed, MEDLINE (OvidSP) and Web of Knowledge in June 2012, 
updated December 2017.  
Eligibility criteria: Studies of hospital-wide admissions from general and acute medical 
wards where preventable deaths rates are provided or can be estimate and which can 
provide inter- observer variations. 
Results: Twenty-four studies were included from 1983-2017. Recent larger studies suggest 
consistently low rates of preventable deaths (3.0-6.5% since 2012). Reliability of a single 
review for distinguishing between individual cases with regard to the preventability of death 
had a Kappa rate of 0.27-0.50 for deaths and 0.24-0.76 for adverse events. A Kappa of 0.35 
would require an average of 8-17 reviews of a single case to be precise enough to have 
confidence about high stakes decisions to change care procedures or impose sanctions 
within a hospital as a result. No study estimated the variation in preventable deaths across 
hospitals, although we were able to re-analyse one study to obtain an estimate. Based on 
this estimate, 200-300 total case-note reviews per hospital could be required to reliably 
distinguish between hospitals.  
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The studies display considerable heterogeneity: 13/24 studies defined preventable with a 
threshold of ≥4 in a six-category Likert scale; 11/24 involved a two-stage screening process 
with nurses at the first stage and physicians at the second. Fifteen studies provided expert 
clinical review support for reviewer disagreements, advice, or quality control. A 
‘generalist/internist’ was the modal physician specialty for reviewers and they received 1-3 
days of generic tools orientation and case-note review practice. Methods did not consider 
the influence of human or environmental factors. 
Conclusions: The literature provides limited information about the measurement 
characteristics of preventable deaths that suggests substantial numbers of reviews may be 
needed to create reliable estimates of preventable deaths at the individual or hospital level. 
Any operational program would require population specific estimates of reliability. 
Preventable death rates are low, which is likely to make it difficult to use SMRs based on all 
deaths to validly profile hospitals. The literature provides little information to guide 
improvements in the measurement procedures.  
Systematic review registration: The systematic review was conceived prior to PROSPERO, 
and so has not been registered. 
 
KEY WORDS: Avoidable, Preventable, hospital deaths, hospital mortality, systematic review, 
variation 
 
SUMMARY BOX 
What is Already Known on This Topic:  
 Numerous studies of adverse events including preventable deaths using implicit 
case-note reviews by clinicians have taken place in recent years, but no systemic 
reviews have aimed to summarise the estimates or the variations in 
methodologies used to derive these estimates. 
 Several health systems have suggested measuring preventable death rates of 
hospitals for comparison across time or in league tables and the use of 
standardized mortality rates to profile hospitals presumes differences in 
preventable deaths. The methodology and optimal review numbers per case note 
or hospital have not been explored. 
What This Study Adds: 
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 Estimates for preventable rates using implicit case-note reviews by clinicians are 
generally low with poor to fair agreement between reviewers seen across 
studies.  
 Low preventable death rates suggest that those using SMRs to rank hospitals will 
need extraordinarily good risk adjustment models to be useful. 
 Based on limited information in the studies substantial numbers of reviews 
would be required for learning from individual cases or profiling hospitals.  
 Population and hospital system specific data on variation across 
hospital/providers to be compared for preventable deaths or adverse events is 
needed to establish adequate numbers of reviews in order to design a 
measurement procedure that can distinguish between the units.  
INTRODUCTION 
Standardized mortality ratios(SMRs) for hospitals are currently used as an indicator of 
institutional quality and compared between hospitals to identify “outliers”.(1) The rationale 
for their use is that they are a proxy for “excess” or preventable deaths, but there are 
compelling arguments that any signal (preventable death) will be obscured by the noise (all 
other unavoidable deaths).(2, 3) Some policy-makers are considering using direct 
measurements of preventable mortality, rather than trying to infer it indirectly from SMRs, 
as with the Summary Hospital-level Mortality Indicator (SHMI) used in the English NHS.(4-7) 
For example, the NHS in England has instituted a system of mandatory physician review of 
deaths in hospital in order to establish (and publish) the number of preventable deaths for 
local Trust use and learning from mistakes.(8, 9)  A direct measurement of preventable 
death is also an obvious way to validate the widespread use of SMRs as a way to measure 
the quality of care delivered to people prior to their death. 
 
However, preventable death, as well as preventable adverse events more broadly, can only 
be directly measured by the judgement of expert clinical observers who retrospectively 
review case-notes. Such judgement-based assessments generally have low reliability, 
meaning that they lack consistency across repeated reviews. Thus, current or future policy 
and research agendas that propose measuring any preventable adverse events, and 
specifically preventable mortality, should push us to define, and if possible improve the 
measurement characteristics of those estimates. Only then can we use case note review 
measurements in research to validate SMRs or consider trying to design operational systems 
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for learning from adverse events within hospitals or even comparing preventable deaths 
between hospitals, possibly augmenting or even replacing comparisons by means of SMRs.  
 
To this end, we conducted a systematic review firstly to summarise data from existing 
studies about the number of avoidable deaths and the measurement characteristics of 
those estimates and apply these in order to determine the number of reviews that would be 
needed to establish a reliable preventable death estimate at the individual or hospital level. 
Secondly, to summarise the heterogeneity between the measurement procedures used in 
these studies including reviewer characteristics, selection and training factors to assess 
whether there are potential opportunities to improve the reliability of the measurement 
procedure. This is the first review of methods to measure preventable mortality rates. 
 
METHODS 
Literature search 
An initial search was undertaken within the PubMed and ISI Web of Knowledge in 2010. This 
was updated and supplemented by a broader search in MEDLINE (OvidSP) incorporating a 
wider range of terms covering preventability and errors, deaths and AEs, hospitals and case-
note reviews in June 2012 and December 2017 (see Appendix 1). After our last search and 
before finalising this manuscript, we were made aware of two studies that met our inclusion 
criteria.(10-12) These studies are included in our review to ensure our findings remain up-
to-date. Reference lists of included studies were also hand-searched to find additional 
articles. 
 
Study selection  
The inclusion criteria were studies which (a) evaluate the preventability of hospital deaths 
(deaths primarily from general and acute medical wards) or preventable AEs contributing to 
death from a hospital-wide sample or primarily from general and acute medical wards; (b) 
provide a quantitative estimate of preventability of death or allow this to be calculated; (c) 
incorporate an implicit review process that elicits the reviewer’s own expert judgment, in 
reaching the conclusion about preventability.  Only articles published in English were 
considered. Two reviewers (authors KKG, PJC or APT) independently examined titles and 
abstracts retrieved from literature searches and selected studies for inclusion. 
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Disagreements were resolved by consensus after retrieval of full-text and further 
discussions with a third reviewer (Y-FC). The review protocol was not submitted to 
PROSPERO as the review process was initiated before the establishment of PROSPERO.  
 
Data extraction and synthesis of evidence 
Two reviewers (KKG, Y-FC, PJC, or APT) extracted data from the selected studies, including 
all data tabulated in Tables 1-3. The characteristics and findings of included studies were 
tabulated and summarized in a narrative form. We did not plan to pool results across 
studies given the underlying differences in settings and methods between the studies. 
Where data was missing, authors were written to and details obtained.  
 
Number of reviewers required for a reliable measurement 
Reliability increases with a measurement procedure that makes multiple independent 
measurements by different reviewers and averages them. Most reports of the reliability of 
case-note review give a number that describes the ability of a single review of any one case 
note to distinguish between patients who died with respect to whether the death was 
preventable. In appendix 2, we describe one method to calculate how the reliability 
increases with the number of reviews. 
 
These commonly reported reliability estimates, which describe the ability to distinguish 
between case-notes of patients who died, can quantify the confidence with which one can 
act on the presumption that a specific avoidable death had occurred, such as by investing in 
doing a root cause analysis to establish proximate causes, or possibly for establishing legal 
liability or compensation for an individual case. However, such reliability estimates tell you 
nothing about determining the performance of different providers, such as different 
hospitals. In any measurement a key determinant of reliability is the variation across the 
things you want to distinguish between and thus to distinguish between hospitals requires 
an estimate of the variation of preventable death rates across hospitals.  
 
No study was found to have published an estimate of this quantity despite its critical 
relevance to any policy making with respect to preventable deaths. We were able to re-
analyse data from one study with 22 hospitals to produce the variance estimates required to 
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make a provisional “best available” calculation of the optimal number of reviews per case 
and per hospital required to produce a reliable estimate of the hospital preventable death 
rate (Appendix 2).(13) Only one other study had quantified hospital variation, finding a 
hospital variance estimate similar in magnitude to the one we estimated, however this was 
for a more global measurement of preventable adverse events that include deaths.(14)  
 
 
RESULTS 
Article retrieval and inclusion (Figure 1) 
The electronic searches yielded 663 records after duplicates had been removed. Citation 
search of included studies identified six additional articles. In all, 37 articles (representing 24 
studies) were included.(10-46) The characteristics of included studies are shown in Table 1. 
The study selection process and reasons for exclusion are summarised in Appendix 3. In 23 
studies, data from publications were inadequate. From these, 14 of the authors written to 
responded. 
[TABLE 1] 
  
Thirteen studies (10-13, 21, 26-33, 36, 38) focused exclusively on the assessment of 
preventable death. Eleven studies (14-20, 22-25, 34, 35, 37, 39-46) primarily aimed to 
evaluate preventable AEs, which included, but were not confined to deaths. All except for 
two studies were in high income-countries conducted between 1984 and 2015 They 
involved a median of 13 hospitals (IQR = 24.25) and 1,068 case-notes (range 10 to 30,121).  
 
Methods for assessing preventable deaths and preventable adverse events contributing to 
deaths 
The majority of the published studies did not have enough details to obtain the information 
required for this review and unpublished data was obtained through author 
communications. Through writing to the authors, we obtained additional data from 13 of 
the 24 studies. These are summarised below in Table 2 and Appendices 4 and 5. 
[TABLE 2]  
 
a) Tools and stages of review (Table 2 and Appendices 4 and 5) 
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A plurality of the studies (10/24) followed the method of the Harvard Medical Practice 
Study,(22) which in turn was based on an approach called structured implicit physician 
review developed by RAND in the 1980s.(47) This measurement procedure includes an 
initial screening of patient notes to identify cases in which it is more likely that an adverse 
event might have occurred. The other studies provided a varied amount information on 
methodology and therefore we wrote to authors for details. These are summarised in Table 
2 and Appendices 4 and 5.  
 
In structured implicit case-note review the structured component guides the reviewer 
systematically and more or less temporally through the hospital admission, asking them to 
focus and rate specific elements of the patient’s care in sequence before making an overall 
judgment about the quality of care.(48) The ‘implicit’ component is inherent in the summary 
judgements produced by the reviewer about the case, as opposed to generating a score 
based on a checklist, as well as the exercise of professional situational judgement in 
deciding whether deviations from ideal processes represent an error or are appropriate in 
the clinical context. A ‘non-structured implicit’ review has been found to be less reliable in 
estimating hospital quality of care, presumably due to the less standardized approach for 
navigating a record and building up to an overall rating.(49, 50) 
 
In our sample, most studies used a kind of structured implicit (or criterion-based implicit) 
review pro forma. Although the details of the structured component varied, in all cases 
adopting structured implicit review, the ‘structured’ component required the reviewer to 
review and make quality judgements over phases of care (such as diagnostic or treatment 
phase). The reviewer was often asked to write explicit comments about areas of concern (as 
free-flow text) for each phase, and finally to score quality for each phase of care.  
 
The decision on preventability was made on a scale applying implicit judgement of the 
physician reviewers. The majority (15/24) of the studies used a 6-category grading system 
(Likert scale) to classify the preventability of deaths and/or AEs.(10, 14-20, 22-25, 32-35, 37-
46) The categories were often collapsed into a binary outcome. Deaths (and/or AEs) with a 
more than 50/50 preventable on balance of probability were considered preventable in 
most studies. Three studies (11-13, 31) used a continuous scale 0-100 probability of 
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preventability comparing it to the Likert scale; the 0-100 scale was found to have the same 
constructs and imparts comparable information to the Likert scale.(13) 
 
Only five studies noted an attempt to anonymise the patient and hospital identifiers in case-
notes (13, 23-25, 31-33) to prevent bias during reviews. No study blinded the reviewers to 
the outcome in these samples selected on the basis of death as the outcome. 
 
b) Reviewer Selection and Training (Table 2 and Appendices 4 and 5) 
All reviewers were external to the institutions from which case-notes were derived to 
reduce internal institutional bias. For reviewer selection, seven studies did not have a first 
stage screening process and deployed only physicians for these reviews.(13, 14, 18, 19, 27-
29, 32, 33, 36, 44-46) Fifteen studies used two-stages, a screening process that involved 
mainly nurses at the first stage and exclusively physician reviewers at the second stage.(10, 
14-26, 31, 34, 35, 38-46) Seven studies used an expert reviewer physician: in six studies they 
settled disagreements between the physician reviewers (14, 16-19, 22-25, 37, 43-46); while 
in one they were for quality control purposes.(39-42) 
 
The required reviewer experience (where recorded) varied widely across the studies in both 
nurses and physicians. For physicians, regular handling of case-notes, a lengthy period of 
clinical work (i.e. often >5 years clinical/reviewing experience), postgraduate education and 
independent accreditation were used. For example, in the US studies, these were board-
certified with the general preference for generalists/internists.(10, 21, 22, 43) The UK 
studies used specialties across general medicine and intensive care consultants.(13, 32, 33, 
38) Eight studies deployed general physicians,(11-19, 22-25, 37, 43-46) and in seven of these 
a panel of specialists were available to advise individual reviewers when required.(11, 12, 
14-19, 22-25, 37, 43-46)  
 
Various forms of reviewer training and support were provided. The training duration varied 
between 1-3 days. Nurses and physicians had the same training in eight studies.(14-20, 22-
25, 35, 37, 44-46) Eleven studies (11/24) are explicit about the exposure to case-notes 
during the training.(10, 13, 14, 18-28, 36, 37, 44-46) Six studies did not disclose reviewer 
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training information. Where enough details were available, training did not define 
preventability, but rather offered clinicians an opportunity to understand the aims, merits 
and some caveats (e.g. hind-sight bias (51, 52)) of the case-note review process, familiarise 
them with the pro forma for data extraction and to exchange views on approaches to 
difficult cases after practicing the review on one or more case-notes.(13, 16, 17, 19, 20, 22-
24, 26, 31-34, 46) 
 
Estimated preventable mortality (Table 3) 
The proportion of deaths judged to be preventable depends upon the cut-off threshold used 
in the Likert scale. Preventable mortality rates as a proportion of ‘all admissions’ were 
estimated between 0.07% and 4.62% (Table 3). Most reports were below 0.7%; the 2.27% 
reported in Brazil (34) and the two Dubois studies (26-28) were exceptionally high. 
Preventability rates as a proportion of ‘all deaths’ were estimated between 0.47% and 29%. 
(10-13, 16-19, 21, 26, 28-34, 36, 38, 43-46, 53, 54) The estimates become more consistent 
when considering only more recent years (2008 to 2017) and high-income countries (3.0–
6.0%). One study chose to estimate preventability at the lowest threshold, namely ‘any 
probability that the death could have been prevented (e.g. ≥2 out of 6).’(23, 24)  
The studies that evaluated preventability of all AEs as a proportion of ‘all admissions’ 
reported generally higher but widely variable figures for AEs, ranging from 1.02% (22) to 
11.65%(16, 17), and preventable AEs as a proportion of ‘all AEs’ ranging from 3.96% (22) to 
70.1%.(37)  
 
Inter-rater reliability (Kappa Statistic) (Table 1) 
Agreements or inter-rater agreements in assessing preventability of death or AEs 
contributing to death were reported in 20 studies.(10-15, 18, 19, 21-28, 30-33, 35-46) 
Cohen’s Kappa statistics are reported for 18 of these 20 studies.(10-13, 15, 21-26, 30-33, 35-
43) Cohen’s Kappa is a statistic that was developed to measure the agreement between 
subjects taking into consideration the agreement that occurs by chance,(55) although for 
these ordinal measures the intra-class correlation would probably be preferred.(56, 57) 
Reported preventable mortality agreements were moderate and ranged from a Kappa of 
0.27 (13) to 0.50.(31) Six studies reported reliabilities for assessing the preventability of all 
AEs (including deaths) (14, 18, 19, 22, 26, 35, 37, 43-46) and the reported AE Kappa ranged 
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from 0.19 to 0.76.(15, 20, 22, 35, 37, 39-43) Six studies report a Kappa for the preventability 
of AEs as judged by physicians, between 0.33 and 0.83.(11, 12, 20, 35, 37, 39-43) One study 
reports a Kappa for nurses of 0.40.(14, 18, 19, 44-46)  
 
No data was found on effects of review selection, characteristics or training on the 
judgement of preventability by the reviewers.  
 
Calculating the optimal number of reviews and reviewers per case note to estimate 
preventable death per case-note and per hospital 
The range of reliability reported for the ability of a single review to distinguish between 
cases was 0.27 to 0.50. At a representative level of reliability of 0.35 for a single review, an 
average of 8 reviews per case-note would be required to achieve a reliability of 0.8 when 
distinguishing between cases. Seventeen reviews per case would be required to achieve a 
reliability of 0.9, a level often recommended for testing with high stakes consequences. 
However, any given operational program would have to determine the reliability of their 
measurement procedure in their population to figure out the number of cases needed to 
review. 
 
About 200-300 total reviews per hospital would be required to reach a reliability of 0.8 for 
distinguishing between hospitals, based on the limited evidence available about the 
between-hospital variance and other components of variance (see Appendix 2 for the 
estimates used and methods to project sample size). Holding the total number of reviews 
constant, increasing the number of reviews per case increases reliability (e.g. 10 reviews per 
case for 30 cases) more than selecting more cases per hospital (150 cases per hospital with 
2 reviews per case). A strategy of only one review per case would provide poor reliability no 
matter how many total reviews were done per hospital. Figure 2 illustrates how the 
reliability changes as the numbers of reviews and reviewers per hospital vary.  
 
It is important to emphasize that more extensive and particularly population specific data 
about the sources of variability in the review procedure could substantially change the 
projected number of reviews needed in either direction. In general, more heterogeneity 
across hospitals, more consistent reviewers, evaluating change over time within hospital, or 
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a focus on relative as opposed to absolute probability of preventable death would result in a 
more modest and feasible number of reviews needed to produce a reliable estimate. 
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DISCUSSION 
We set out to review the literature on measuring preventable deaths and determine if it 
would allow us to project how many reviews and reviewers would be required for a/ 
hospitals to learn lessons from reviewing preventable deaths and b/ for a hospital system to 
profile hospitals based on their preventable death rates. Secondarily, we looked at whether 
the literature contained any information on how the reliability of physician implicit review 
to identify preventable deaths could be improved by refining the measurement procedure. 
To this end we conducted a review of studies of preventable hospital deaths published from 
1980-2015.  
 
The first important finding is that the preventability of death was relatively low in the 
reviewed studies and this has important consequences for using deaths to assess quality of 
care. While some studies did vary the probability thresholds and Likert scale anchors for 
defining preventability as described above, most studies used a similar operational 
definition of more than a 50/50 chance on balance of probability for defining that a death 
was preventable. A low prevalence of preventable death should substantially heighten 
concern about using SMRs calculated from discharge data to profile hospitals. If 95% of 
deaths are non-preventable, detection of  outlier hospitals has an extremely low positive 
predictive value(3) and any mis-specification of risk adjustment models can also introduce 
substantial bias.  
 
Another important finding is the lack of any published estimates in the literature of how 
much variation there is in preventable death rates across hospitals. Without this it is 
impossible to estimate the reliability for distinguishing between hospitals with respect to 
their preventable death rates or design an operational program to do so. Using direct 
measurement, we estimated that as many as 300 or more total reviews could be required 
per hospital to distinguish between hospitals in a league table with high stakes relegation 
and promotion consequences. Additionally, holding the total number of reviews per 
hospitals constant, the optimal number of cases per hospital and reviews per case would 
require trade-offs to ensure the maximum generalizability and precision. 
 
Furthermore, recall that the purpose of comparing SMRs is explicitly to identify differences 
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in preventable or avoidable death rates for which the SMR is just a proxy. If the variation in 
SMRs across hospitals is substantially larger than the variation in preventable death rates as 
directly measured or the rates are not correlated, it would raise concern that SMRs are 
measuring something else, most likely unmeasured case-mix differences.  Yet, in the 
absence of this critical piece of information that could support or call into question the 
validity of SMRs, profiling hospitals based on SMRs is ubiquitous and in the U.S. is tied to 
significant and increasing financial risk to hospitals.  
 
The literature does provide more data about the reliability of a single measurement to 
distinguish individual cases with respect to whether a preventable death or preventable 
adverse event more generally occurred. This reliability estimate is relevant for quality 
reviews of sentinel cases by hospitals to learn from possible mistakes or for reviews by 
licensing boards or for cases subject to litigation. It is clear that high reliability is desirable 
before possible sanctions or changes in procedures are contemplated on the basis of a 
judgement that a preventable death has occurred. For a typical reliability of 0.35 from the 
fairly wide range observed, an average of between 8-17 reviewers could be required to 
reliably distinguish between patients with respect to whether a preventable death occurred.  
This is far larger than is commonly used for credentialing, legal cases or sentinel case and 
root cause analysis reviews. 
 
However, providing these specific calculations as examples should not obscure the more 
important point that different measurement questions and different patient and hospital 
populations will each require their own estimates of reliability. These reliability estimates 
can then in turn be used to develop question and population specific calculations of the 
number of reviewers and reviews per record required so that an estimate with the required 
precision can be obtained. The numbers may vary substantially with the setting and 
question. 
 
We also summarise variation in the measurement procedures across studies (Appendix 5). 
We provide previously unpublished and summary data about many aspects of the 
procedures used as it was often not reported in the published papers. While the assessment 
methods had areas in common across the studies, on the whole they were quite 
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heterogeneous. We found no empirical assessment of how single vs two stage assessments, 
pro forma tools, reviewer selection or training, reviewer characteristics or environmental 
influences effect consistency of measurement. Formal reliability or generalizability studies 
to evaluate different aspects of training and measurement procedures could be built in to 
an operational program to facilitate improvements in the reliability of measurement. Details 
of these criteria and methodological issues are discussed as related to existing literature in 
Appendix 5.  
 
Finally, It is worth re-iterating that the structured implicit case-note review method was 
originally designed to measure quality, not preventable death, and has a large literature 
describing its use for this purpose.(58)  We should perhaps abandon attempts to measure 
the absolute proportion of deaths that are preventable as an impossible quest.(13) 
Physicians are not good at estimating prognostic survival probabilities much less the even 
more challenging counterfactual probabilities like “what is the probability of survival if an 
event had not occurred” which raises concern about the validity of such estimates.(59-61)  
Rather, structured implicit review could be used to directly measure the quality of care in 
the period before a patient’s death, in keeping with how these methods were originally 
designed when developed 30 to 50 years ago.(47, 62-64)  
 
The systematic review component of this study has several limitations. Due to practical 
reasons, we excluded studies not published in English. We found a large variation in the 
reported preventable mortality, but with only a limited number of studies we are unable to 
confirm the exact source of the observed heterogeneity. We have focused on overall 
hospital mortality and acute general medicines in this review. 
 
CONCLUSIONS 
Based on available information, preventable deaths comprise a relatively small fraction of 
preventable deaths raising concerns about the feasibility of using SMRs as a proxy for 
preventable deaths.    Structured implicit review is a challenging measurement task and it is 
likely that relatively large numbers of reviews are needed either to allow learning from 
individual cases or to compare hospitals.  However, there is a critical lack of any reported 
estimates of the hospital variance in preventable death rates which is required to design 
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systems in a responsible way to profile hospitals based on preventable death rates, whether 
measured directly or indirectly. There is little evidence about factors that affect the 
consistency of case-note reviews other than reviewer experience and agreement between 
reviewers remain poor to moderate.  
 
Any operational system assessing hospital quality around deaths will need to invest in a 
substantial ongoing effort to quantify the variation across hospitals and reviewers, as well as 
evaluate how the selection and training of the reviewers and measurement procedures can 
make the reliability more consistent (see Appendix 5 for an expanded discussion).(65) 
Attempting to measure preventable deaths on an absolute scale would require engagement 
with the behavioural science and cognitive psychology literature, pertinent to human and 
system-wide errors (66) in healthcare,(67) that best locate the ‘bounded rationality’ of 
human decision-making,(68) and the biases that plague it.(69, 70) However, whether 
measuring preventable deaths, or quality more generally, those who want to profile 
providers must recognize that no program can be designed to distinguish between providers 
without stable estimates of the amount of variation that exists across those providers. 
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FIGURE LEGENDS 
Figure 1: Review flow diagram of article retrieval and inclusion 
Figure 2: Reliability for up to 300 reviews per hospital.  
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TABLES 
Table 1. Characteristics of included studies and methods used for assessing the preventability of deaths or adverse events (AEs)  
Author 
Location 
and Date 
Target 
Group / 
Type of 
hospital 
Grading of 
preventability* 
Threshold 
for defining a 
preventable 
case 
% agreement, 
Kappa (ICC) for 
preventability 
Inter-hospital 
Variance/ICC 
Comments 
Dubois, et 
al. 
1987.(27, 
28)  
US. 1985 12 
private 
hospitals 
1-4† ≥3† 
Death as 
‘probably 
preventable’ 
Pearson 
correlation: 0.71 
preventability of 
death 
(a single 
independent 
physician review 
of 30 charts) 
Not reported  Hospital-wide medical wards 
with conditions specific to 
cerebrovascular accident, 
pneumonia and myocardial 
infarction. 
 Acute-care hospitals that 
were considered outliers with 
higher and lower than 
expected mortality 
 PM estimated from data 
 27% of deaths (of all deaths) 
were preventable 
Dubois & 
Brook. 
1988.(26) 
US. 1985 12 
private 
hospitals 
1-4† ≥3† 
Death as 
‘probably 
preventable’ 
69%, κ =0.4, 0.3 
and 0.2‡ 
preventability of 
death 
(182 charts each 
reviewed by 
three physicians) 
Not Reported  Hospital-wide medical wards 
with conditions specific to 
cerebrovascular accident, 
pneumonia and myocardial 
infarction. 
 Acute-care hospitals that 
were considered outliers with 
higher and lower than 
expected mortality 
 PM estimated from data 
 14% of deaths (of all deaths) 
were preventable 
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Brennan, 
et al. 
1991.(22) 
New York, 
USA. 1984 
51 
private 
and non-
federal 
acute 
care 
hospitals 
 
1-6 ≥4 
negligence is 
more likely 
than not 
93%, κ =0.24 / 
preventability of 
AE (based on 
duplicated review 
of 318 cases 
[2/51 hospitals] 
 
Not Reported  Hospital-wide excluding 
psychiatric patients. 
 Non-federal, acute-care hospitals 
 PM estimated from data. 
 Weighted figures based on 
events discovered during index 
hospitalisation only. 
 13.6% of patients with AEs died. 
Hayward, 
et al. 
1993.(10) 
USA, 1988-
1990 
1 
teaching 
hospital 
1-6 ≥5 
better quality 
care could 
have 
prevented the 
death 
κ =0.5 
Death 
preventable by 
better quality of 
care 
(based on 
multiple reviews 
of 34 deaths (80 
comparisons) 
with 122 reviews 
in total) 
N/A (Insufficient 
Denominator) 
 Hospital-wide medical wards with 
no single diagnostic-related 
group contributing ≥5% of patient 
admissions. 
 Acute-care university teaching 
hospital 
 9% of patient deaths preventable 
Best & 
Cowper. 
1994.(21) 
USA, 1986 16 
Veteran 
Affair 
Medical 
Centers 
1-4 ≥3 
Somewhat 
likely that 
better 
management 
in the hospital 
might have 
prevented 
patient’s 
death 
κ =0.33 
‘agreement = ≤ 2 
positions on 9-
point scale’ 
(111 match-pairs 
from high and 
low mortality risk 
Veteran Affairs 
Medical Centers) 
 
Not Reported  Veteran Affairs Medical Centers 
(Small, med/large and 
Psychiatric/long term types) 
 21.6% of patient with better care 
management might have 
prevented death (or near the time 
of death) 
Wilson et 
al. 
1995.(43) 
New South 
Wales & 
South 
Australia. 
1992 
28 
private 
and 
public 
acute 
care 
hospitals 
 
1-6 ≥4 
"Preventability 
more likely 
than not, 
more than 
50/50 but 
close call" 
58%, κ =0.33 / 
preventability of 
AE 
(based on 
duplicated review 
of 6200 cases [all 
cases positive for 
screening 
criteria]) 
Not Reported  Hospital-wide excluding day-only 
admissions & admissions to 
psychiatric wards. 
 Preventable AEs and PM 
estimated from data. 
 4.9% of patients with AEs died. 
Pre-Print Version 
19 
 
Thomas 
et al. 
1999, 
2000a, 
2000b & 
2002.(39-
42)  
 
Utah & 
Colorado, 
USA. 1992 
28 
private 
and 
public 
hospitals 
 
1-6 
 
≥4 
"More likely 
than not, 
>50:50 but 
close call" 
κ =0.19 to 0.23 
(95% CI 0.05 to 
0.37)) 
preventability of 
AE 
(based on 3 
independent 
reviews of 500 
records) 
Not Reported  Hospital-wide (13 in Utah and 15 
in Colorado) excluding 
psychiatric and veteran hospitals 
and patients < 16. 
 Number of patients with AEs not 
specified, only total number of 
AEs. 
 Based on events discovered 
during index hospitalisation only 
 6.6% of patients with AEs died. 
Hayward 
& Hofer. 
2001.(31) 
USA. 1994-
1995 
7 
Veterans 
Affairs 
hospitals 
 
1-5§ ≥4§ 
"probably" - 
was the death 
preventable 
by optimal 
care 
ICC=0.34 / 
preventability of 
Death 
(based on 383 
review of 111 
cases) 
N/A (Insufficient 
Denominator) 
 Hospital-wide excluding data of 
patients receiving comfort care 
and non-veterans. 
 Public Hospitals 
 Patients with hospital-acquired 
laboratory abnormality over-
sampled 
 Reviewed deceased patients 
only 
Davis et 
al. 2001; 
2003.(24, 
25) 
 
Briant, et 
al. 
2006.(23) 
New 
Zealand. 
1998 
13 public 
acute 
care 
hospitals 
 
1-6 ≥4 
"Close call, 
>50:50" 
Not reported Not Reported  Hospital-wide excluding 
specialist institutions. 
 Public hospitals 
 Over all hospitals there were: 
850 AEs; 315 avoidable AEs ≥4; 
531 ≥2 
 4.5% of patients with AEs died. 
 6.1% of avoidable AEs; unclear 
concerning disability/death 
status. 
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Baker, et 
al. 
2004.(20) 
Canada. 
2000 
20 public 
acute 
care 
hospitals 
 
1-6 ≥4 
"Preventability 
more than 
likely (more 
than 50/50, 
but close 
call)" 
κ =0.69, (95% CI 
0.55-0.83) / 
preventability of 
AE 
(based on 
duplicated review 
of a random 
sample of 10% 
cases) 
Not Reported 
(Hospital Size 
Groupings 
preclude de 
novo 
calculation) 
 Hospital-wide excluding 
psychiatric and obstetric 
hospitals, day-only admission 
and patients < 18. 
 Acute-care hospitals 
 Weighted percentages to 
account for total charts per 
hospital and hospitals per type 
per province. 
 15.7% of patients with AEs died 
Michel, et 
al. 
2007.(35) 
France. 
2004 
71 
private 
and 
public 
hospitals 
 
1-6 ≥4 
"more likely 
than not" 
67.8%, κ = 0.31 
(95% CI 0.05-
0.57) / 
preventability of 
AE 
(based on 58 
cases judged to 
have AE by both 
reviewers) 
Not Reported  Hospital wide excluding obstetric 
hospitals. 
 Retrospective case-note review 
& 7-day observation with data 
collection across 294 wards. 
 Patients with (preventable) AEs 
not noted. 
 8.2% of patients with AEs died 
Soop, et 
al. 
2009.(37) 
Sweden. 
2003-2004 
28 public 
acute 
care 
hospitals 
 
1-6 ≥4 
"more than 
50% 
likelihood" 
91%, κ = 0.76 / 
preventability of 
AE 
(based on 
duplicated review 
of 642 cases [all 
cases positive for 
screening 
criteria]) 
Not Reported  Hospital-wide excluding 
psychiatric, rehabilitation and 
palliative hospitals and day-only 
admission. 
 Acute-care hospitals with high 
proportion of elderly patients; all 
deaths occurred in 
elderly/critically ill patients. 
 Preventable mortality estimated 
from data. 
 4.1% of patients with AEs died. 
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Aranaz-
Andres, et 
al. 
2008(17); 
2009(16) 
Spain. 2005 24 public 
hospitals 
 
1-6 ≥4 
"positive" - 
not defined 
Not reported 
 
Not Reported  Hospital-wide 
 Retrospective cohort study. 
 Patients had 655 AEs; 278 
preventable AEs (with at least 
moderate evidence). 
 Patients with preventable AEs 
estimated based on 42.6% of 
AEs were preventable 
 Retrospective cohort study. 
 4.4% of patients with AEs died. 
Kappa was reported only for the 
identification of AEs between 
reviewers and ‘gold standards’. 
Aranaz-
Andres, et 
al. 
2011.(15) 
Argentina, 
Colombia, 
Costa Rica, 
Mexico and 
Peru 2005 
58 public 
hospitals 
 
1-6 ≥4 
"positive" - 
not defined 
κ ranged from 
0.27 to 0.74 
between 
countries / 
preventability of 
AE 
(sample size not 
stated) 
Not Reported  Hospital-wide 
 Retrospective case-note review 
and prospective data collection. 
 Preventable mortality estimated 
from data 
 5.8% of patients with AEs died 
Martins, 
et al. 
2011.(34) 
Brazil, 2003 3 
teaching 
hospitals 
 
1-6 ≥4 
(wording not 
described) 
Not reported Not Reported  Hospital-wide; including obstetric 
wards. 
 38% of patients with AEs died. 
Hogan, et 
al. 
2012.(32) 
England. 
2009 
10 acute 
hospitals 
 
1-6 ≥4 
“Probably 
preventable, 
more than 
50/50 but 
close call" 
k=0.49 (95% CI 
0.2-0.8) / 
preventability of 
Death, based on 
duplicated review 
of 250 cases 
(25% of sample) 
“There were no 
significant 
differences 
between 
proportions of 
preventable 
deaths found at 
each hospital.” 
(32) p.740 
 Hospital-wide excluding obstetric 
& psychiatric wards, paediatric 
patients & palliative care. 
 100 cases randomly selected 
from each acute hospital 
 Reviewed deceased patients 
only 
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Sorinola, 
et al. 
2012.(38) 
England. 
2009 
1 acute 
hospital 
1-6 ≥4 
‘Preventable 
death’ 
κ =0.75 
Preventability of 
Death 
Inter-rater 
reliability across 
reviewers of a 
‘determination of 
a problem in 
care’ 
(from sample of 
400 notes) 
N/A (Insufficient 
Denominator) 
 Hospital-wide excluding obstetric 
& psychiatric wards, paediatric 
patients & palliative care. 
 400 death cases selected 
consecutively in 2009 
 Preventable mortality estimated 
from data 
Gupta, et 
al. 
2013.(30) 
US. 2009-
2012 
1 acute 
hospital 
1-5 ≥4 
‘Possibly 
preventable’ 
κ =0.10 
Preventability of 
Death 
agreement 
between the 
mortality 
committee 
classification and 
provider 
classification 
(Notes sample 
size not 
provided) 
N/A (Insufficient 
Denominator) 
 Hospital-wide 
 2,483 died, 1683 had surveys 
completed 
 Preventable mortality estimate 
provided 
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Baines, et 
al. 2013; 
2015.(18, 
19)  
 
Zegers, et 
al. 2007; 
2009; 
2011a; 
2011b. 
(14, 44-
46) 
The 
Netherlands 
2004 & 
2008 
33 acute 
hospitals 
1-6 ≥4 
AE was found 
to be 
preventable 
when the care 
did not 
comply with 
existing 
professional 
standards 
and/or due to 
shortcomings 
of a 
healthcare 
practitioner, 
management 
or system. 
2004 
AE 
Positive 
agreement (+) 
54.9% 
Negative 
Agreement (-) 
66.2% 
(400 admissions 
randomly 
reviewed) 
2008 
AE 
Positive 
agreement (+) 
54.9% 
Negative 
Agreement (-) 
82.9% 
(200 admissions 
randomly 
reviewed) 
 
Preventable 
AEs ICC = 
3.7% (hospital-
level) 
 Hospitals including palliative care 
and excluding psychiatric, 
obstetric and paediatric patients 
 Hospitals were randomly 
selected on location 
 Reviewed patients discharged 
alive and deceased patients 
 Higher proportion of preventable 
AEs in deceased than patients 
discharged alive 
Hogan et 
al. 2015. 
(33) || 
England 
2012/13 
24 acute 
hospitals 
1-6 ≥4 
Probably 
avoidable, 
more than 50-
50 
κ =0.45 (95% CI 
0.24-0.66) / 
based on random 
sample of 486 
avoidable Death 
cases (grade 4-6) 
Not Reported  Hospitals excluding obstetric, 
psychiatric and paediatric 
patients 
 100 cases randomly selected 
from each acute hospital 
 Reviewed only deceased 
patients 
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Manaseki-
Holland et 
al. 2016. 
(13) ¶ 
England & 
Wales 
2003-2009 
22 
hospitals 
1-5 ≥3 
On the 
balance of 
probability 
(i.e. > 50% 
chance) 
κ =0.27 (95% CI 
0.19-0.39) intra-
class correlation 
across a single 
review 
 
Not Reported  Hospitals with inclusion of only 
respiratory conditions from 
medical wards 
 191 case-notes for those 
admitted with respiratory 
complaints and 65 years and 
over 
 Case-notes randomly assigned 
to 2-7 reviewers. (Total of 653 
reviews) 
Flaatan, 
et al. 
2017.(29) 
Norway 
2011 
3 acute 
hospitals 
1-5 ≥4 
‘Possibly 
preventable’ 
Not reported Not reported  All hospital deaths across 3 
hospitals in 2011 (incl. 
Emergency department) 
 1185 deaths notes reviewed 
across 1 year period 
 Case notes assigned to six 
consultant reviewers each from 
different specialties 
Kobewka, 
et al. 
2017.(11, 
12) 
Canada 
2013 
1 acute 
hospital 
0-100 50 
‘Possibly 
preventable’ 
Reliability=0.68** 
ICC=0.14 
(480 deaths each 
reviewed by 4 
reviewers) 
N/A (Insufficient 
Denominator) 
 Hospital excluding paediatrics 
 480 deceased case-notes 
(structure case abstracts) 
produced across 3-month 
admission period 
 Case-notes randomly assigned 
to 4 physician reviewers 
Roberts, 
et al. 
2017.(36) 
UK 
2012-2015 
4 North-
East 
England, 
UK acute 
care 
Trusts 
1-6 (PRISM) 
1-5 (NCEPOD) 
≥4 (PRISM) 
≥3 (NCEPOD) 
 
κ=0.45 (PRISM) 
κ=N/A 
(NCEPOD) 
(Not provided) 
N/A  All hospital deaths across 4 
Trusts 
 7370 medical records reviewed 
 Case notes reviewed 
predominantly by consultants, 
some by nurses. 
* Scale of degree of preventability. This tends to range from “6, (virtually) certain evidence of preventability” through to “1 (virtually) 
no evidence for preventability”.  
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† We have reversed the scale to facilitate comparisons with other studies. The original scale ranged from 1 (definitely) preventable 
death through to 4 (definitely not) preventable deaths. Cases with a grade of 2 or lower (probably or definitely), on the original 
scale, were considered as preventable. 
‡ For cerebrovascular accident, myocardial infarction and pneumonia, respectively. 
§ We have reversed the scale to facilitate comparisons with other studies. The original scale ranged from 1 (definitely) preventable 
death through to 5 (definitely not) preventable deaths. Cases with a grade of 2 or lower (probably or definitely), on the original 
scale, were considered as preventable. 
|| “In your judgment, is there some evidence that the patient’s death was avoidable if the problem/s in healthcare had not occurred?” 
¶ The ‘England’ study has been extracted from the 2016 paper as the ‘US’ data has been included in Hofer & Hayward (2001). We 
have reversed the scale to facilitate comparisons with other studies. The original scale ranged from 1 (definitely) preventable death 
through to 5 (definitely not) preventable deaths. Cases with a grade of 2 or lower (probably or definitely), on the original scale, were 
considered as preventable. 
** Mean reliability across four reviewers.
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Table 2. Summary of study processes and review methods 
Category No. References 
Inclusion of a 
Screening Stage 
No screening stage 4 (32, 33, 36, 37) 
Yes (16-18), criteria) 15 (10, 14-26, 31, 34, 35, 38-46) 
Trigger tool 4 (15, 26, 34, 38) 
Scale used for implicit 
judgement 
Binary 0  
4 point Likert 2 (21, 26) 
5 point Likert 3 (13, 31, 36) 
6 point Likert 16 (10, 14-20, 22-25, 32-46) 
Continuous 2 (11-13) 
Reviewer Screening 
Stage 1 
Physician 7 (13, 14, 18, 19, 27-29, 32, 33, 36, 44-46) 
Nurse 11 (14-19, 21-25, 34, 35, 37-42, 44-46) 
Pharmacist 1 (38) 
Reviewer Review 
Stage 2 
Physician Expert Advice 
Available 
15 (14-25, 27, 28, 34-46) 
Pharmacist support 0  
Nurse support 0  
Duration of Expert 
Advice 
Indefinite duration 3 (10, 33, 36) 
Temporary duration 3 (16, 17, 21, 23-25) 
No stated duration 2 (13, 33) 
Reviewer affiliations External to the institution 
being reviewed 
20  (10-26, 31-35, 37-46)* 
Internal 2 (21, 36)* 
Hospital 
Anonymisation 
Undertaken 5 (13, 23-25, 31-33) 
NOT undertaken 17 (10-12, 14-22, 26-28, 34-46) 
Clinical Experience of 
Physicians 
< 5 years 0  
5-10 years 4 (11, 12, 15-17, 20)  
> 10 years 7 (21, 32-34, 36, 37, 43) 
Previous experience not 
mentioned 
2 (10, 39-42) 
No mention of experience 5 (22-28, 35) 
Speciality of 
Physicians 
General medicine/Internal 
medicine (Alone) 
13 (10, 15-17, 20-25, 32, 34, 35, 37, 38, 43) 
Internal medicine & 
specialists 
9 (11-14, 18, 19, 21, 26, 31, 33, 36, 39-42, 
44-46) 
Review Discrepancies 
and Disagreements 
Reconciled 
Physicians 3 (14, 18, 19, 36, 43-46) 
Nurses 0  
Medical Health Analysts / 
Records Analyst 
1 (22) 
Executive Board 2 (16, 17, 37) 
Information not available 6 (20, 21, 23-28, 39-42) 
Physician Reviewer 
Training Duration 
≤ 1 day 7 (14, 18, 19, 21, 23-25, 27, 28, 32, 33, 38, 
44-46) 
1 - 3 days 7 (13, 20, 31, 34, 36, 39-43) 
≥ 3 days 3 (16, 17, 35, 37) 
Not stated 4 (10-12, 15, 26) 
Training Content Case-note Exposure 12 (10, 13, 14, 18-28, 31, 36, 37, 44-46) 
Specialist Advice 
Provided 
8 (14, 16-19, 21, 23-25, 27, 28, 31, 32, 36, 
44-46) 
Absence of Preventability 
definition 
18 (10, 13-20, 22-26, 31-35, 37-46) 
Familiarity with study tools 14 (10, 13, 14, 18-25, 27, 28, 33, 34, 36-42, 
44-46) 
* Best, et al. (1994) (21) was half external and half internal.
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Table 3. Preventable mortality and/or adverse events reported in the included studies 
Author No. of 
admitted 
patient case 
notes 
reviewed 
(with or 
without 
initial 
screening) 
[a] 
No. of 
deceased 
patient case 
notes 
reviewed [b] 
No. of 
admission 
case notes 
selected after 
screening for 
review [c] 
Preventable 
AEs (% of 
admissions) 
Preventable 
AEs (% of  all 
AEs [c]) 
  
Preventable 
mortality (% of 
admissions [a]) 
Preventable 
mortality (% of 
deceased [b]) 
Threshold for preventability & 
comments 
Dubois, et al. 
1987. (28, 
53)(USA) 
NR 182 NR NR NR NR 26.9%  
49/182 
Preventability score 3 out of 4* 
Dubois & 
Brook. 1988. 
(26)(USA) 
1,946 182 NR NR NR 
 
4.6% 
90/1,946 
26.9%  
49/182  
 
14%  
25/182 
Preventability score 3 out of 4* 
(majority decision) 
 
Preventability score 3 out of 4* 
(unanimous decision) 
Brennan, et al. 
1991. 
(22)(USA) 
30,121 NR 7,743 306 (1.02% 
weighted) 
 
3.96% 
306/7743 
 
 
 
0.30% 
89/30, 121 
NR Causation score 1 on a 0-6 scale 
Preventability score  4 out of 6 
 
Hayward, et al. 
1993. 
(10)(USA) 
675 NR NR NR NR 
 
0.44% 
3/675 
9%  
3/34 
Preventability score 4 out of 6 
Best & 
Cowper. 1994. 
(21)(USA) 
NR 222*** NR NR NR 
 
NR 21.6% median Preventability score 3 out of 4" 
Wilson, et al. 
1995. 
(43)(Australia) 
14,179 114 1,718 1,205 (8.50%)† NR 
 
0.55% 
78/14,179 
29.00% Causation score 2 out of 6 
 
Preventability score 4 out of 6 
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Thomas, et al. 
1999, 2000a, 
2000b & 2002.  
(39-42)(USA) 
 
  
14,700 NR 448 3.00% 
448/14, 700 
NR 
 
0.265% 
39/14,700 
NR Causation score 4 out of 6; 
Preventability: ‘an adverse event 
was considered preventable if it 
was avoidable by any means 
currently available unless that 
means was not considered 
standard care.’ 
 
The implicit judgement methods 
are similar to those used in Bates, 
et al. 1997.[70] 
Hayward & 
Hofer. 
2001.(31) 
(USA) 
NA 111 NA NA NR 
 
0.23% - 0.61% 
(at least possibly 
preventable) 
(95% CI) 
22.7%; 
6.0% 
 
Preventability score 3 out of 5§ 
Preventability score 4 out of 5§ 
 
(preventable scores weighted to 
account for over-sampling of 
patients with laboratory 
abnormality) 
Davis, et al. 
2001; 2003.  
Briant, et al. 
2006. 
(23, 24)(New 
Zealand) 
6,579 118 850 6.28% 
413/6,579 
48.6% 
413/850 
 
0.36% 
24/6579 
19.8 – 20.7% Preventability score Not Reported 
(NR) 
Causation score 2 out of 6 
Preventability score 2 out of 6  
Baker, et al. 
2004. (54)‡ 
(Canada) 
3,692 236 1512 2.8% (95% CI 
2.0% to 3.6%)^ 
7.01% 
106/1,512 
 
0.66% (95% CI 
0.37% -0.95%)^ 
(death from 
preventable AE) 
16.9%  
40/236§ 
Causation score ³4 out of 6  
Preventability score 4 out of 6 
(Preventability score Not 
Reported (NR) §) 
Michel, et al. 
2007.  
(35)(France) 
8,754 NR NR 1.08% 
95/8,754 
NR 
 
0.09%  
8/8,754 
NA Preventability score Not Reported 
(NR) 
Causation score 4 out of 6 
Preventability score 4 out of 6  
Soop, et al. 
2009.  
(37)(Sweden) 
1,967 10 241 8.6% 
169/1,967 
70.1% 
169/241 
 
0.25%  
5/1,967 
NR Causation score 4 out of 6 
Aranaz-
Andres, et al. 
2008; 2009. 
(16, 
17)(Spain)  
5,624 225 1,755 11.65% 
655/5,624 
37.3% 
655/1,755 
 
0.07% 
5/5,624¶ 
4.5% Causation score 4 out of 6 
Preventability score 4 out of 6 
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Aranaz-
Andres, et al. 
2011.(15)  
(Argentina, 
Colombia, 
Costa Rica, 
Mexico and 
Peru) 
11,379 NR 1,754 10.47% 
1,191/11,379 
67.9% 
11,91/1,754 
 
0.32 
780*0.058 
72?/11,379 
NR Causation score ≥4 out of 6  
Preventability score ≥4 out of 6 
Martins, et al. 
2011.  
(34)(Brazil) 
1,103 94 1,103 5.07% 
56/1,103 
5.07% 
56/1,103 
 
8.50% 26.6% 
25/94 
Causation score ≥4 out of 6  
Preventability score ≥4 out of 6 
Hogan, et al. 
2012.** 
(32)(England) 
NR 1000 NR NR NR 
 
NR 5.2% 
52/1,000 
Preventability score ≥4 out of 6 
(reporting 1 of 3) 
Sorinola, et al. 
2012. 
(38)(England) 
NR 400 NR NR NR 
 
NR 3.5%  
14/400 
Preventability score 4 out of 6 
Gupta, et al. 
2013. 
(30)(USA) 
NR 1,683 NR NR NR 
 
NR 2.50% 
42/1,683 
Preventability score ≥4 out of 5 
Baines, et al. 
2013; 2015.   
Zegers, et al. 
(18, 19, 44-
46)2007; 
2009; 2011a; 
2011b. (The 
Netherlands) 
11,949 762 1,130 NR NR 
 
NR 4.5%  Preventability score ≥4 out of 6 
Hogan, et al. 
2015.(33) †† 
(England) 
NR 2,400 NR NR NR 
 
NR 3% 
101/2,400 
Preventability score ≥4 out of 6  
Manaseki-
Holland, et al. 
2016. 
(13)(England) 
NR 191µ NR NR NR 
 
NR 10% (median)  
Q1 3%  
Q3 28% 
Preventability score ≤2 out of 5 
Pre-Print Version 
30 
 
Flaatten, et al. 
2017. 
(29)(Norway) 
59,605 1,167 NR NR NR 
 
0.057% 
34/59,605 
2.91% 
34/1,167 
Preventability score ≥ 50 out of 
100 
Kobekwa, et al. 
2017. (11, 
12)(Canada) 
14,267 480µ NR NR NR 
 
0.22% 
31/14,267 
6.46% 
31/480‡‡ 
Preventability score ≥ 50 out of 
100†† 
Roberts, et al. 
2017. 
(36)(UK) 
NR 7,194 NR NR NR 
 
NR 0.47% 
34/7,194 
Preventability score ≥ 50 out of 
100 
 
Causation score is the score given to the likelihood of the adverse event being caused by medical care/management: causation score 2 out of 6 corresponds to ‘at least slight to modest evidence of 
management causation’; causation score 4 out of 6 corresponds to ‘management causation more likely – more than 50/50’.  
Preventability score 2 out of 6 corresponds to ‘at least slight to modest evidence of preventability’. Preventability score 4 out of 6 corresponds to ‘preventability more than likely – more than 50/50’. 
* We have reversed the scale to facilitate comparisons with other studies. The original scale ranged from 1 (definitely) preventable death through to 4 (definitely not) preventable deaths. Cases with a 
grade of 2 or lower (probably or definitely), on the original scale, were considered as preventable. 
† This indicator is for deaths considered with a high level of preventability. 
‡ Of all Adverse events = 459 50% probability of membership in the “possibly preventable” class. 
§ Figures are taken from direct author response rather than published data. 
^ Adjusted for sampling frame. 
¶ Associated with preventable AE. 
** “Was the patient’s death due to problems in the healthcare or did problems in healthcare contribute to the death?” 
*** Pairs were matched across high observed-to-expected mortality ~(OTEM) and low OTEM Veteran affairs hospitals 
†† “In your judgment, is there some evidence that the patient’s death was avoidable if the problem/s in healthcare had not occurred?” 
‡‡ 50% probability of membership in the “possibly preventable” class 
µ multiple reviews were undertaken with the case notes 
NA = Not Assessed; NR = Not Reported 
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